These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12963633)

  • 41. Stereotactic radiosurgery and fractionated stereotactic radiotherapy in the treatment of uveal melanoma.
    Henderson MA; Shirazi H; Lo SS; Mendonca MS; Fakiris AJ; Witt TC; Worth RM; Timmerman RD
    Technol Cancer Res Treat; 2006 Aug; 5(4):411-9. PubMed ID: 16866571
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Traumatic enucleation for posterior uveal melanoma.
    Specht CS; McLean IW; Biscoe BW
    Am J Ophthalmol; 1990 Nov; 110(5):518-21. PubMed ID: 2240138
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The risk of enucleation after proton beam irradiation of uveal melanoma.
    Egan KM; Gragoudas ES; Seddon JM; Glynn RJ; Munzenreider JE; Goitein M; Verhey L; Urie M; Koehler A
    Ophthalmology; 1989 Sep; 96(9):1377-82; discussion 1382-3. PubMed ID: 2550868
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surgery vs. radiotherapy in patients with uveal melanoma : Analysis of the SEER database using propensity score matching and weighting.
    Jang BS; Chang JH; Oh S; Lim YJ; Kim IH
    Strahlenther Onkol; 2017 Nov; 193(11):931-942. PubMed ID: 28879443
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Intratumoral blood pools and prognosis of malignant uveal melanoma treated with enucleation].
    Kantelip B; Albuisson E; Bacin F; Bonhomme R
    Ophtalmologie; 1989; 3(1):49-52. PubMed ID: 2641072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of uveal tract melanoma: A comprehensive review.
    Kapoor A; Beniwal V; Beniwal S; Mathur H; Kumar HS
    J Egypt Natl Canc Inst; 2016 Jun; 28(2):65-72. PubMed ID: 26975730
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Enucleation in patients with intraocular melanomas].
    Stoiukhina AS; Davydov DV
    Vestn Oftalmol; 2010; 126(2):51-6. PubMed ID: 21105381
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quality of life in the follow-up of uveal melanoma patients after enucleation in comparison to CyberKnife treatment.
    Klingenstein A; Fürweger C; Mühlhofer AK; Leicht SF; Schaller UC; Muacevic A; Wowra B; Hintschich C; Eibl KH
    Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):1005-12. PubMed ID: 26573389
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quality of life: fractionated stereotactic radiotherapy versus enucleation treatment in uveal melanoma patients.
    van Beek JGM; Buitendijk GHS; Timman R; Muller K; Luyten GPM; Paridaens D; Naus NC; Kiliç E
    Acta Ophthalmol; 2018 Dec; 96(8):841-848. PubMed ID: 30284368
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Radiation therapy: before or after enucleation.
    van Peperzeel H
    Doc Ophthalmol; 1980 Dec; 50(1):71-3. PubMed ID: 7472139
    [No Abstract]   [Full Text] [Related]  

  • 51. Analysis of melanoma cell type in uveal melanoma following treatment failure.
    Kivelä T; Toivonen P
    Am J Ophthalmol; 2005 Oct; 140(4):768; author reply 768-9. PubMed ID: 16226549
    [No Abstract]   [Full Text] [Related]  

  • 52. Pre-enucleation irradiation of uveal melanoma.
    Char DH; Phillips TL
    Br J Ophthalmol; 1985 Mar; 69(3):177-9. PubMed ID: 3884038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The current aspects of the treatment of uveal melanomas].
    Brovkina AF
    Vestn Oftalmol; 1999; 115(3):3-6. PubMed ID: 10432841
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma.
    Marucci L; Lane AM; Li W; Egan KM; Gragoudas ES; Adams JA; Collier JM; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1018-22. PubMed ID: 16376492
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
    Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
    Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The pathological basis of the argument in the treatment of melanoma of the uveal tract].
    Li YP
    Zhonghua Yan Ke Za Zhi; 2012 Nov; 48(11):971-5. PubMed ID: 23302268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The role of beta-ray therapy in the treatment of choroidal and ciliary body melanomas].
    Grange JD; Gérard JP; Ragab M; Delaroche G; Jean-Louis B; Bievelez B; Sentenac I; Baute B
    Ophtalmologie; 1989; 3(3):175-9. PubMed ID: 2641104
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current alternatives in the management of posterior uvea melanomas.
    Shields JA; Shields CL; Shah P; DePotter P
    Trans Pa Acad Ophthalmol Otolaryngol; 1990; 42():938-44. PubMed ID: 2084990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of prognosis after enucleation vs cobalt 60 irradiation of melanomas.
    Gass JD
    Arch Ophthalmol; 1985 Jul; 103(7):916-23. PubMed ID: 4015482
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proton therapy for uveal melanoma in 43 juvenile patients: long-term results.
    Petrovic A; Bergin C; Schalenbourg A; Goitein G; Zografos L
    Ophthalmology; 2014 Apr; 121(4):898-904. PubMed ID: 24405742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.